Linking factor XIII activity to all-cause mortality after myocardial infarction: the overlooked role of serum albumin
Authors:
Open Access
- 12 September 2025
- journal article
- Published by Elsevier in IJC Heart & Vasculature
- Vol. 61, 101796
Abstract
No abstract availableKeywords
Funding Information
- German Research Foundation
This publication has 9 references indexed in Scilit:
- Hypoalbuminaemia and Heart Failure: A Practical Review of Current EvidenceEuropean Journal of Heart Failure, 2024
- Association of Hypoalbuminemia With Clinical Outcomes in Patients Admitted With Acute Heart FailureCurrent Problems in Cardiology, 2023
- Prognostic Impact of Follow-Up Serum Albumin After Acute Myocardial InfarctionESC Heart Failure, 2021
- Coagulation Factor XIII Activity Predicts Left Ventricular Remodelling After Acute Myocardial InfarctionESC Heart Failure, 2020
- Coagulation factor XIII: a multifunctional transglutaminase with clinical potential in a range of conditionsThrombosis and Haemostasis, 2015
- Factor XIII-A dynamics in acute myocardial infarction: a novel prognostic biomarker?Thrombosis and Haemostasis, 2015
- HypoalbuminemiaInternal and Emergency Medicine, 2012
- Transglutaminase activity in acute infarcts predicts healing outcome and left ventricular remodelling: implications for FXIII therapy and antithrombin use in myocardial infarctionEuropean Heart Journal, 2008
- Factor XIII Deficiency Causes Cardiac Rupture, Impairs Wound Healing, and Aggravates Cardiac Remodeling in Mice With Myocardial InfarctionCirculation, 2006